NCT04796727

Brief Summary

While 80 % of all sudden cardiac death (SCD) result from coronary artery disease (CHD) approximatively 2/3 of SCD occur as a first manifestation of the CHD. VF (ventricular fibrillation) is the main cause of SCD in acute coronary syndrome (ACS), and the 2017 ESC Guidelines for the management of acute myocardial infarction, recommended direct admission to the catheterization laboratory in survivors of out of hospital cardiac arrest (OHCA) with criteria for STEMI on the post-resuscitation electrocardiogram (ECG) (Class I, grade B). However, During the past few years, the number of immediate coronary angiography (CA) for suspected ACS in patients presenting an OHCA increased, with a survival rate at discharge in this subgroup of patients better, about 60 to 80% (1). However, the survival rate remains poor in the global population of OHCA and some survivors patients may have neurological sequelles, related to global anoxia consequences or altered quality of life related to cardiac function impairement . While the survival rate at hospital discharge is well known, the investigators have few data on long term outcomes , particularly regarding cardiac and neurological states. Therefore the main objective of this study is to evaluate prospectively, in an observational study, the one-year prognosis of patients with rescuscited OHCA in whom a CA for suspected ACS was performed in the university hospital of Montpellier. Only patients alive at discharged are considered for the follow-up to eliminate the in-hospital mortality . The investigators aim to assess year neurological status using medical questionnaires at one year follow-up(primary end point). The investigators hypothesize that 10% of patients will discharged alive from hospital with severe neurological sequelae at 1 year.Secondary end point will evaluate cardiac status, quality of life and pronostic factors of adverse outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 15, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

November 11, 2021

Status Verified

November 1, 2021

Enrollment Period

9 months

First QC Date

February 25, 2021

Last Update Submit

November 10, 2021

Conditions

Keywords

neurological stateCardiological stateQuality of lifeCoronary angiographyOne year mortalityCardiac ventsOne year quality of lifeNeurological events

Outcome Measures

Primary Outcomes (5)

  • Incidence of patients alive without neurological sequelae

    Incidence of patients alive without neurological sequelae at one year follow up after out of hospital cardiac arrest. Neurological status will be evaluated with the Cerebral Performance Category score. Patients with a score of 1 or 2 will be considered without neurological sequelae. Grade 1 correspond to patients with normal cerebral performance and grade 2 to patients with moderate cerebral disability but don't need any support for daily activities. Grade 3 is for patients with severe disability leading to daily support. Grade 4 is for coma or vegetative state and Grade 5 for brain death.

    1 year

  • Incidence of patients alive

    Incidence of patients alive Incidence of patients alive without neurological sequelae (CPC 1 or 2)

    3 months

  • Incidence of patients alive

    Incidence of patients alive Incidence of patients alive without neurological sequelae (CPC 1 or 2)

    1 year

  • Rate of hospitalizations

    Rate of hospitalizations (from cardiovascular cause)

    1 year

  • Rate of hospitalizations

    Rate of hospitalizations (from cardiovascular cause)

    3 months

Secondary Outcomes (2)

  • Cardiac functional status

    1 year

  • Cardiac functional status

    3 months

Study Arms (1)

OHCA

300 OHCA admitted directly to the cathlab and alive at discharge during a 2 years period of enrolement.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients older than 18 who are admitted directly to our cath lab for a cardiopulmonary arrest and alive at discharge.

You may qualify if:

  • Older than 18 years old.
  • Out of Hospital Cardiac arrest
  • Coronary angiography in emergency
  • Alive at discharge.

You may not qualify if:

  • Absence of return of spontaneous circulation after reanimation.
  • Admission in a resuscitation unit before the coronary angiography.
  • In-hospital death.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

Related Publications (2)

  • Patel N, Patel NJ, Macon CJ, Thakkar B, Desai M, Rengifo-Moreno P, Alfonso CE, Myerburg RJ, Bhatt DL, Cohen MG. Trends and Outcomes of Coronary Angiography and Percutaneous Coronary Intervention After Out-of-Hospital Cardiac Arrest Associated With Ventricular Fibrillation or Pulseless Ventricular Tachycardia. JAMA Cardiol. 2016 Nov 1;1(8):890-899. doi: 10.1001/jamacardio.2016.2860.

  • von Steinbuchel N, Wilson L, Gibbons H, Hawthorne G, Hofer S, Schmidt S, Bullinger M, Maas A, Neugebauer E, Powell J, von Wild K, Zitnay G, Bakx W, Christensen AL, Koskinen S, Formisano R, Saarajuri J, Sasse N, Truelle JL; QOLIBRI Task Force. Quality of Life after Brain Injury (QOLIBRI): scale validity and correlates of quality of life. J Neurotrauma. 2010 Jul;27(7):1157-65. doi: 10.1089/neu.2009.1077.

MeSH Terms

Conditions

Heart Arrest

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Florence Leclercq, PU PH

    University Hospital, Montpellier

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2021

First Posted

March 15, 2021

Study Start

August 1, 2019

Primary Completion

May 1, 2020

Study Completion

May 1, 2021

Last Updated

November 11, 2021

Record last verified: 2021-11

Locations